SPONSOR
Mediar Therapeutics
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Healthy Adult ParticipantsDiabetic Kidney DiseaseIdiopathic Pulmonary FibrosisDiffuse Cutaneous Systemic Sclerosis
Mediar Therapeutics is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Healthy Adult Participants, Diabetic Kidney Disease, Idiopathic Pulmonary Fibrosis, Diffuse Cutaneous Systemic Sclerosis.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Mediar Therapeutics
How many clinical trials has Mediar Therapeutics sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Mediar Therapeutics, of which 3 are actively recruiting participants. These trials cover conditions including Healthy Adult Participants, Diabetic Kidney Disease, Idiopathic Pulmonary Fibrosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Mediar Therapeutics research focus on?
Mediar Therapeutics clinical trials span Healthy Adult Participants, Diabetic Kidney Disease, Idiopathic Pulmonary Fibrosis, Diffuse Cutaneous Systemic Sclerosis. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Mediar Therapeutics clinical trial?
To participate in a Mediar Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Mediar Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Mediar Therapeutics
NCT07473323 Phase 1
Recruiting
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
Healthy Adult Participants
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
NCT07287670 Phase 2
Recruiting
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Diffuse Cutaneous Systemic Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology